NEW YORK, NY / ACCESS Newswire / February 5, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Jasper Therapeutics, Inc. ("Jasper" or "the Company") (NASDAQ:JSPR). Investors who purchased Jasper securities prior to November 30, 2023, and continue to hold to the present, are encouraged to obtain additional […]

NEW YORK CITY, NY / ACCESS Newswire / February 5, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pacira BioSciences, Inc. ("Pacira" or "the Company") (NASDAQ:PCRX). Investors who purchased Pacira securities prior to August 2, 2023, and continue to hold to the present, are encouraged to obtain

NEW YORK, NY / ACCESS Newswire / February 5, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sun Communities, Inc. ("Sun Communities" or "the Company") (NYSE:SUI). Investors who purchased Sun Communities securities prior to February 28, 2019, and continue to hold to the present, are encouraged to

Full Swing, the industry leader in pioneering sports technology, and Back Nine, one of the country’s fastest-growing franchises, have forged an exclusive partnership that is redefining how golfers experience simulator golf. Built on a shared commitment to innovation, authenticity and performance, the partnership unites Full Swing’s cutting-edge simulator technology and Back Nine’s frictionless indoor golf

Schweiger has been named a leading dermatology practice in the United States by Castle Connolly earning one of the highest national distinctions among dermatology practices, in addition to multiple statewide #1 rankings. In the 2026 Castle Connolly Accolades, Schweiger received five prestigious practice honors, including being ranked #2 Physician Practice in the Nation for Dermatology,

Toronto, Ontario–(Newsfile Corp. – February 5, 2026) – Douglas Lee, Director, Global Equity Derivatives, TD Securities, along with other members from TD Securities, BMO Capital Markets, and Société Générale, joined Ron Hochman, Managing Director, CRM Equity Derivatives, Montreal Exchange (MX), to open the market and celebrate MX recently launching the Adjusted Interest Rate S&P/TSX 60

NEW YORK CITY, NY / ACCESS Newswire / February 5, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avantor, Inc. ("Avantor" or "the Company") (NYSE:AVTR). Investors who purchased Avantor securities prior to March 5, 2024, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / February 5, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aquestive Therapeutics, Inc. ("Aquestive" or "the Company") (NASDAQ:AQST). Investors who purchased Aquestive securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/AQST.

NEW YORK CITY, NY / ACCESS Newswire / February 5, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Semler Scientific, Inc. ("Semler" or "the Company") (NASDAQ:SMLR). Investors who purchased Semler securities prior to March 10, 2021, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / February 5, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RxSight, Inc. ("RxSight" or "the Company") (NASDAQ:RXST). Investors who purchased RxSight securities prior to November 7, 2024, and continue to hold to the present, are encouraged to obtain additional